Portolan Capital Management - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Portolan Capital Management ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,822,259
-54.3%
108,632
-49.5%
0.25%
-57.5%
Q1 2023$6,176,954
+0.4%
215,075
+3.5%
0.59%
-3.8%
Q4 2022$6,153,840
+10.2%
207,900
-11.4%
0.61%
+3.6%
Q3 2022$5,584,000
+6.0%
234,603
-0.6%
0.59%
+11.3%
Q2 2022$5,267,000
+142.5%
235,972
+370.3%
0.53%
+239.7%
Q2 2021$2,172,000
+695.6%
50,177
+551.0%
0.16%
+403.2%
Q3 2020$273,000
-26.2%
7,708
-21.5%
0.03%
-26.2%
Q2 2020$370,000
+16.0%
9,814
-11.0%
0.04%
-12.5%
Q1 2020$319,000
-57.5%
11,032
-23.7%
0.05%
-36.8%
Q4 2019$750,000
-5.5%
14,4610.0%0.08%
-15.6%
Q3 2019$794,000
+26.6%
14,461
-6.3%
0.09%
+34.3%
Q2 2019$627,000
+41.5%
15,428
+5.3%
0.07%
+45.7%
Q1 2019$443,000
-88.9%
14,656
-87.6%
0.05%
-90.7%
Q4 2018$3,983,000
-28.1%
118,509
-9.8%
0.49%
-9.7%
Q3 2018$5,542,000
+6.8%
131,382
-18.9%
0.55%
+3.2%
Q2 2018$5,187,000
+80.1%
162,080
+179.8%
0.53%
+68.3%
Q1 2018$2,880,000
+266.9%
57,932
+298.0%
0.32%
+266.3%
Q4 2017$785,000
-7.1%
14,556
-0.1%
0.09%
-14.9%
Q3 2017$845,000
+17.5%
14,5660.0%0.10%
+9.8%
Q2 2017$719,000
+11.8%
14,566
-1.6%
0.09%
+9.5%
Q1 2017$643,000
-80.7%
14,807
-78.2%
0.08%
-81.2%
Q4 2016$3,324,000
+6.4%
67,892
+4.0%
0.45%
+4.4%
Q3 2016$3,123,000
+12.9%
65,275
+26.6%
0.43%
+7.8%
Q2 2016$2,765,000
-52.8%
51,540
-60.6%
0.40%
-49.2%
Q1 2016$5,856,000
-68.6%
130,939
-73.2%
0.78%
-66.8%
Q4 2015$18,645,000
-8.3%
488,595
-23.5%
2.36%
-12.3%
Q3 2015$20,335,000
+24.5%
638,849
+29.2%
2.70%
+18.0%
Q2 2015$16,330,000
+8.8%
494,413
+35.7%
2.28%
-17.0%
Q1 2015$15,005,000
+19.5%
364,463
+18.3%
2.75%
+9.5%
Q4 2014$12,553,000
+35.4%
308,131
+21.9%
2.51%
+19.4%
Q3 2014$9,269,000
-7.8%
252,833
+16.5%
2.10%
-4.2%
Q2 2014$10,058,000
+39.1%
217,105
+23.4%
2.20%
+32.0%
Q1 2014$7,232,000
+42.7%
175,964
+32.5%
1.66%
+48.1%
Q4 2013$5,069,000
+47.4%
132,832
-7.7%
1.12%
+24.8%
Q3 2013$3,439,000
+9.7%
143,958
-21.9%
0.90%
+0.9%
Q2 2013$3,135,000184,4310.89%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Caligan Partners LP 1,081,360$20,145,7379.25%
Trigran Investments, Inc. 2,217,019$41,303,0654.40%
DIKER MANAGEMENT LLC 50,239$935,9530.84%
Virtus Investment Advisers, Inc. 45,579$849,1370.58%
Virtus Fund Advisers, LLC 3,490$65,0190.46%
CAPITAL MANAGEMENT CORP /VA 84,225$1,569,1120.35%
Riverwater Partners LLC 17,597$327,8320.30%
BOOTHBAY FUND MANAGEMENT, LLC 617,602$11,505,9250.27%
XTX Topco Ltd 28,033$522,2550.09%
GSA CAPITAL PARTNERS LLP 51,638$9620.08%
View complete list of ANIKA THERAPEUTICS INC shareholders